1. Home
  2. Analysis
  3. Herceptin
  4. Mcp

Herceptin and Mcp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Herceptin (trastuzumab) and Mcp (pectin). Common drug interactions include dizziness among females.

The phase IV clinical study analyzes what interactions people have when they take Herceptin and Mcp. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Herceptin?

Herceptin has active ingredients of trastuzumab. It is often used in breast cancer. eHealthMe is studying from 42,205 Herceptin users. Check the latest studies of Herceptin.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

On Aug, 12, 2026

41 people who take Herceptin and Mcp together, and have interactions are studied.

Herceptin and Mcp drug interactions.

What are the common drug interactions of Herceptin and Mcp, by gender? *:

female:

  1. Dizziness
  2. General physical health deterioration (weak health status)
  3. Leukopenia (less number of white blood cells in blood)
  4. Pyrexia (fever)
  5. Anaemia (lack of blood)
  6. Hypokalaemia (low potassium)
  7. Asthenia (weakness)
  8. Atrioventricular block (heart block)
  9. Cachexia (loss of weight)
  10. Device occlusion

male:

n/a

What are the common drug interactions of Herceptin and Mcp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dizziness
  2. Erysipelas (bacterial skin infection)
  3. Mucosal inflammation (infection of mucous membrane)
  4. Nausea (feeling of having an urge to vomit)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Vomiting
  7. General physical health deterioration (weak health status)
  8. Neuropathy peripheral (surface nerve damage)
  9. Burning sensation
  10. Diarrhoea

50-59:

n/a

60+:

  1. General physical health deterioration (weak health status)
  2. Dehydration (dryness resulting from the removal of water)
  3. Dyspnoea (difficult or laboured respiration)
  4. Gait disturbance
  5. Hypokalaemia (low potassium)
  6. Pneumonia
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Pyrexia (fever)
  9. Urinary tract infection
  10. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

What are the existing conditions these people have? *

  1. Nausea And Vomiting: 17 people, 41.46%
  2. High Blood Pressure: 10 people, 24.39%
  3. Nausea (feeling of having an urge to vomit): 9 people, 21.95%
  4. Depression: 9 people, 21.95%
  5. Pain: 8 people, 19.51%
  6. Arrhythmias (irregular heartbeat): 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Herceptin and Mcp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Herceptin and Mcp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Herceptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mcp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Herceptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mcp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on trastuzumab and pectin (the active ingredients of Herceptin and Mcp, respectively), and Herceptin and Mcp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.